| | Class 2 Device Recall ToxCup |  |
| Date Initiated by Firm | August 18, 2020 |
| Create Date | September 30, 2020 |
| Recall Status1 |
Terminated 3 on September 30, 2024 |
| Recall Number | Z-3045-2020 |
| Recall Event ID |
86335 |
| 510(K)Number | K032057 K122633 |
| Product Classification |
Enzyme immunoassay, cocaine and cocaine metabolites - Product Code DIO
|
| Product | ToxCup Drug Screen Cup (AMT Item Number/ AMT Description):
HT29A/"ToxCup Drug Screen Cup
COC300/MET500/OPI300/THC50/AMP1000/PCP25/OXY100
Adulteration Screen for CR - NI - PH - BL - S.G.",
DT14/ "ToxCup Drug Screen Cup
THC50/COC150; OPI300/MET500; AMP500/BZO300; BAR300/MTD300; BUPG10/TCA1000; MDMA500/OXY100; PCP25/PPX300",
HT15/ "ToxCup Drug Screen Cup
AMP1000/COC300/MET500/PCP25/ THC50/OPI2000",
HT15A/ ToxCup Drug Screen Cup
AMP1000/COC300/MET500/PCP25/ THC50/OPI2000
Adulteration Screen for CR - NI - PH - BL - S.G.",
PT15/ "ToxCup Drug Screen Cup
AMP1000/COC300/MET500/OPI300/THC50"
DT13A/ "ToxCup Drug Screen Cup
THC50/COC150; OPI300/MET500; AMP500/BZO300; BAR300/MTD300; BUPG10/TCA1000; MDMA500/OXY100
w/ Cr, Ni, pH, BI, S.G.",
DT14A "ToxCup Drug Screen Cup
THC50/COC150; OPI300/MET500; AMP500/BZO300; BAR300/MTD300; BUPG10/TCA1000; MDMA500/OXY100; PCP25/PPX300
w/ Cr, Ni, pH, Bl, S.G. Finished Devices",
DT12A/"ToxCup Drug Screen Cup
THC50/COC150; OPI300/MET500; AMP500/BZO300; BAR300/MTD300; MDMA500/OXY100; PCP25/PPX300 w/ Cr, Ni, pH, BI, S.G.",
PT12A/ "ToxCup Drug Screen Cup
COC300/MET500/OPI2000/PCP25/THC50
Adulteration Screen for CR - NI - PH - BL - S.G.",
PT11A/ "ToxCup Drug Screen Cup
AMP1000/COC300/OPI2000/PCP25/THC50
Adulteration Screen for CR - NI - PH - BL - S.G.",
HT30/ "ToxCup Drug Screen Cup
AMP1000/COC300/MET1000/PCP25/THC50/ OPI2000" |
| Code Information |
ALL Lots Within Expiry |
| FEI Number |
3003789989
|
Recalling Firm/ Manufacturer |
Ameditech Inc 9940 Mesa Rim Rd San Diego CA 92121-2910
|
| For Additional Information Contact | Ms. Angela Occhionero 858-619-4969 |
Manufacturer Reason for Recall | Various immunoassay enzymes failed product performance, thereby the products do not consistently detect all calibrator and secondary compounds at the levels stated in the labeling. |
FDA Determined Cause 2 | Process control |
| Action | A Field Corrective Action Notice letter was sent to affected consignees. The Customer notifications commenced on 19-Aug-2020. The consignees are requested to return all non-expired product in their possession to the recalling firm.
Method of Notification, 1st contact: Written field corrective action notification letters will be sent via certified mail with delivery tracking to each consignee along with a pre-paid return label to return any product remaining in stock. 2nd & 3rd contact: Telephone, follow up email, or written mail communication will be used as necessary. |
| Quantity in Commerce | 189,175 units |
| Distribution | US - Nationwide
OUS - Australia, France, Germany, New Zealand, Singapore and Spain |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = DIO
|
|
|
|